Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis.
Adimadhyam S, Lewis JD, Simon AL, Wolfe AE, Smith S, Hou L, Moyneur É, Reynolds JS, Toh S, Dobes A, Parlett L, Haynes K, Burris J, Dorand JE, Long MD, Kappelman MD.
Adimadhyam S, et al. Among authors: simon al.
Inflamm Bowel Dis. 2024 Apr 3;30(4):554-562. doi: 10.1093/ibd/izad115.
Inflamm Bowel Dis. 2024.
PMID: 37358904